| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |